(Q34307569)

1 August 2017

1 reference

title

The role of carbohydrate in the assembly and function of polymeric IgG. (English)

1 reference

1 August 2017

Coloma MJ

1

1 reference

1 August 2017

Clift A

series ordinal

2

1 reference

1 August 2017

Wims L

series ordinal

3

1 reference

1 August 2017

Morrison SL

series ordinal

4

1 reference

1 August 2017

1 December 2000

1 reference

1 August 2017

1 reference

1 August 2017

37

1 reference

1 August 2017

18

1 reference

1 August 2017

1081-1090

1 reference

Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

IgM polymerization inhibits the Golgi-mediated processing of the mu-chain carboxy-terminal glycans

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Identification of the Fc gamma receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Primate erythrocyte-immune complex-clearing mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Tumour localization and pharmacokinetics of iodine-125 human monoclonal IgM antibody (COU-1) and its monomeric and half-monomeric fragments analysed in nude mice grafted with human tumour

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Aglycosylated chimeric mouse/human IgG1 antibody retains some effector function

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

The binding site for C1q on IgG

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Immune adherence and the processing of soluble complement-fixing antibody/DNA immune complexes in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Multiple roles for the major histocompatibility complex class I- related receptor FcRn

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Cooperative binding by mouse IgG3 antibodies: implications for functional affinity, effector function, and isotype restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

IgG pair formation on one antigenic molecule is the main mechanism of synergy between antibodies in complement-mediated lysis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Recombinant expression of polymeric IgA: incorporation of J chain and secretory component of human origin

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Finally! The Brambell receptor (FcRB). Mediator of transmission of immunity and protection from catabolism for IgG.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Structural basis of the interaction between IgG and fcγ receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRn

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement component C1 and interaction with human monocyte Fc receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Multiple binding sites on the CH2 domain of IgG for mouse Fc gamma R11.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Oligosaccharide-protein interactions in IgG can modulate recognition by Fc gamma receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Characterization of the glycosylation of a human IgM produced by a human-mouse hybridoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

A colorimetric-enzymatic microassay for the quantitation of antibody-dependent complement activation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Substitution of asparagine324 with aspartic acid in the Fc portion of mouse antibodies reduces their capacity for C1q binding

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Biological significance of carbohydrate chains on monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Glycosylation is influential in murine IgG3 self-association

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

The stoichiometry and affinity of the interaction of murine Fc fragments with the MHC class I-related receptor, FcRn

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Investigation of the interaction between the class I MHC-related Fc receptor and its immunoglobulin G ligand.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Mapping and comparison of the interaction sites on the Fc region of IgG responsible for triggering antibody dependent cellular cytotoxicity (ADCC) through different types of human Fc gamma receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Developmental regulation of IgM secretion: the role of the carboxy-terminal cysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Recombinant polymeric IgG: an approach to engineering more potent antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Structural requirements for incorporation of J chain into human IgM and IgA.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

The differential ability of human IgG1 and IgG4 to activate complement is determined by the COOH-terminal sequence of the CH2 domain

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing Fc gamma RI and/or Fc gamma RII receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Interaction of a human Fc gamma RIIb1 (CD32) isoform with murine and human IgG subclasses

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor(,)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900024-4

7 January 2021

10.1016/S0161-5890(01)00024-4

Identifiers

DOI

1 reference

1 August 2017

1 reference